These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 27355941

  • 41. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
    Chen PH, Cheng CH, Shih CM, Ho KH, Lin CW, Lee CC, Liu AJ, Chang CK, Chen KC.
    PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811
    [Abstract] [Full Text] [Related]

  • 42. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
    Han J, Chen Q.
    Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
    [Abstract] [Full Text] [Related]

  • 43. Targeting Gliomas: Can a New Alkylating Hybrid Compound Make a Difference?
    Pinheiro R, Braga C, Santos G, Bronze MR, Perry MJ, Moreira R, Brites D, Falcão AS.
    ACS Chem Neurosci; 2017 Jan 18; 8(1):50-59. PubMed ID: 27665765
    [Abstract] [Full Text] [Related]

  • 44. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.
    Zheng LT, Lee S, Yin GN, Mori K, Suk K.
    J Neurochem; 2009 Dec 18; 111(5):1238-51. PubMed ID: 19860839
    [Abstract] [Full Text] [Related]

  • 45. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
    Yeh WL, Lin HY, Huang CY, Huang BR, Lin C, Lu DY, Wei KC.
    Oncotarget; 2015 Nov 10; 6(35):37770-81. PubMed ID: 26473373
    [Abstract] [Full Text] [Related]

  • 46. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells.
    Wang L, Ye X, Cai X, Su J, Ma R, Yin X, Zhou X, Li H, Wang Z.
    Oncotarget; 2015 Jul 20; 6(20):18027-37. PubMed ID: 26046466
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione.
    Yang DI, Yin JH, Ju TC, Chen LS, Hsu CY.
    Free Radic Biol Med; 2004 May 15; 36(10):1317-28. PubMed ID: 15110396
    [Abstract] [Full Text] [Related]

  • 49. Growth of precultured human glioma specimens in nude rat brain.
    Engebraaten O, Hjortland GO, Hirschberg H, Fodstad O.
    J Neurosurg; 1999 Jan 15; 90(1):125-32. PubMed ID: 10413165
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II.
    Xu H, Chen Q, Wang H, Xu P, Yuan R, Li X, Bai L, Xue M.
    J Exp Clin Cancer Res; 2016 Nov 16; 35(1):178. PubMed ID: 27852319
    [Abstract] [Full Text] [Related]

  • 53. Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kurpad SN, Dolan ME, McLendon RE, Archer GE, Moschel RC, Pegg AE, Bigner DD, Friedman HS.
    Cancer Chemother Pharmacol; 1997 Nov 16; 39(4):307-16. PubMed ID: 9025771
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
    Hassouna I, Sperling S, Kim E, Schulz-Schaeffer W, Rave-Fränk M, Hasselblatt M, Jelkmann W, Giese A, Ehrenreich H.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):927-34. PubMed ID: 19014782
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress.
    Poschmann G, Grzendowski M, Stefanski A, Bruns E, Meyer HE, Stühler K.
    Biochim Biophys Acta; 2015 Jun 01; 1854(6):624-31. PubMed ID: 25484280
    [Abstract] [Full Text] [Related]

  • 58. [Intranasal administration of temozolomide for brain-targeting delivery: therapeutic effect on glioma in rats].
    Li Y, Gao Y, Liu G, Zhou X, Wang Y, Wang Y, Ma L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 May 01; 34(5):631-5. PubMed ID: 24849425
    [Abstract] [Full Text] [Related]

  • 59. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M, Diesler K, Majhen D, Steigerwald C, Berte N, Freund H, Stojanović N, Kaina B, Osmak M, Ambriović-Ristov A, Tomicic MT.
    Oncotarget; 2017 Apr 25; 8(17):27754-27771. PubMed ID: 27487141
    [Abstract] [Full Text] [Related]

  • 60. Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide.
    Kokkinakis DM, Bocangel DB, Schold SC, Moschel RC, Pegg AE.
    Clin Cancer Res; 2001 Feb 25; 7(2):421-8. PubMed ID: 11234899
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.